Invention Grant
- Patent Title: MAPK/ERK kinase inhibitors
- Patent Title (中): MAPK / ERK激酶抑制剂
-
Application No.: US12520247Application Date: 2007-12-18
-
Publication No.: US08293901B2Publication Date: 2012-10-23
- Inventor: Qing Dong , Nicholas Scorah , Steven W Kaldor
- Applicant: Qing Dong , Nicholas Scorah , Steven W Kaldor
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agent David M. Stemerick; Mitchell R. Brustein
- International Application: PCT/US2007/087913 WO 20071218
- International Announcement: WO2008/079814 WO 20080703
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/519 ; A61P35/00

Abstract:
Compounds of the following formula are provided for use with MEK (I): wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Public/Granted literature
- US20100130518A1 MAPK/ERK KINASE INHIBITORS Public/Granted day:2010-05-27
Information query